دورية
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.
العنوان: | PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity. |
---|---|
المؤلفون: | Akturk, Halis Kaan, Alkanani, Aimon, Zhao, Zhiyuan, Yu, Liping, Michels, Aaron W |
المصدر: | The Journal of Clinical Endocrinology & Metabolism; October 2018, Vol. 103 Issue: 10 p3589-3592, 4p |
مستخلص: | Immune checkpoint inhibitors, including monoclonal antibodies directed against programmed cell death protein 1 (PD-1) and its ligand, have emerged as beneficial cancer immunotherapies. These therapies are known to cause immune-related side effects; however, their role in patients with a preexisting autoimmune disease is not clear. |
قاعدة البيانات: | Supplemental Index |
تدمد: | 0021972X 19457197 |
---|---|
DOI: | 10.1210/jc.2018-01430 |